ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,827.04
      -1.54%
      US Tech 100
      20,263.20
      -1.69%
      Dow Jones
      41,938.45
      -1.63%
      Brent Oil
      79.285
      0.00%
      Bitcoin
      94,359.70
      -0.37%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Embecta Corporation (EMBC) Quote

      Embecta Corporation

      Embecta Corporation (EMBC)

      NASDAQ
      19.48
      -0.77
      (-3.80%)
      Closed January 11 4:00PM
      Delayed by 15 minutes
      19.48
      -0.01
      (-0.05%)
      After Hours: 7:59PM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      19.48
      Bid
      18.79
      Ask
      20.33
      Volume
      258,151
      19.17 Day's Range 20.18
      9.925 52 Week Range 21.48
      Market Cap
      1.132B
      Previous Close
      20.25
      Open
      20.08
      Last Trade
      6100
      @
      19.48
      (priorref)
      Last Trade Time
      Financial Volume
      $ 5,050,860
      VWAP
      19.5655
      Average Volume (3m)
      402,354
      Shares Outstanding
      58,130,561
      Dividend Yield
      3.08%
      PE Ratio
      14.47
      Earnings Per Share (EPS)
      1.35
      Revenue
      1.12B
      Net Profit
      78.3M

      About Embecta Corporation

      Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others. Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.

      Sector
      Surgical,med Instr,apparatus
      Industry
      Surgical,med Instr,apparatus
      Website
      www.embecta.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Embecta Corporation is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker EMBC. The last closing price for Embecta was $20.25. Over the last year, Embecta shares have traded in a share price range of $ 9.925 to $ 21.48.

      Embecta currently has 58,130,561 shares outstanding. The market capitalization of Embecta is $1.18 billion. Embecta has a price to earnings ratio (PE ratio) of 14.47.

      Ask ADVFN Intelligence (AI)

      EMBC Latest News

      More News

      embecta to Participate at the 43rd Annual J.P. Morgan Healthcare Conference

      PARSIPPANY, N.J., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will present at the J.P. Morgan Healthcare Conference in San Francisco...

      December 19 2024
      GlobeNewswire Inc.

      Form ARS - Annual Report to Security Holders

      December 19 2024
      Edgar (US Regulatory)

      Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

      December 19 2024
      Edgar (US Regulatory)

      Form DEF 14A - Other definitive proxy statements

      December 19 2024
      Edgar (US Regulatory)

      Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

      December 11 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      December 04 2024
      Edgar (US Regulatory)

      Form 3 - Initial statement of beneficial ownership of securities

      December 04 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      December 02 2024
      Edgar (US Regulatory)

      Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

      November 29 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      November 29 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.74-3.6597428288820.2221.2319.4447968920.31345989CS
      4-0.2-1.016260162619.6821.231946421920.2520887CS
      125.8542.92002934713.6321.4813.0540235418.14673794CS
      267.6464.52702702711.8421.4811.540530416.25732145CS
      521.015.4683270167818.4721.489.92541191714.89263336CS
      156-12.88-39.802224969132.3636.649.92561695823.5925111CS
      260-12.88-39.802224969132.3636.649.92561695823.5925111CS

      EMBC - Frequently Asked Questions (FAQ)

      What is the current Embecta share price?
      The current share price of Embecta is $ 19.48
      How many Embecta shares are in issue?
      Embecta has 58,130,561 shares in issue
      What is the market cap of Embecta?
      The market capitalisation of Embecta is USD 1.18B
      What is the 1 year trading range for Embecta share price?
      Embecta has traded in the range of $ 9.925 to $ 21.48 during the past year
      What is the PE ratio of Embecta?
      The price to earnings ratio of Embecta is 14.47
      What is the cash to sales ratio of Embecta?
      The cash to sales ratio of Embecta is 1.01
      What is the reporting currency for Embecta?
      Embecta reports financial results in USD
      What is the latest annual turnover for Embecta?
      The latest annual turnover of Embecta is USD 1.12B
      What is the latest annual profit for Embecta?
      The latest annual profit of Embecta is USD 78.3M
      What is the registered address of Embecta?
      The registered address for Embecta is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
      What is the Embecta website address?
      The website address for Embecta is www.embecta.com
      Which industry sector does Embecta operate in?
      Embecta operates in the SURGICAL,MED INSTR,APPARATUS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      VRMEVerifyMe Inc
      $ 2.57
      (52.98%)
      		57.83M
      WKEYWISeKey International Holdings AG
      $ 10.041
      (52.83%)
      		6.72M
      DATSDatChat Inc
      $ 4.8105
      (49.86%)
      		158.65M
      CDTConduit Pharmaceuticals Inc
      $ 0.1214
      (48.05%)
      		1.17B
      INTZIntrusion Inc
      $ 2.8888
      (44.44%)
      		40.61M
      IGMSIGM Biosciences Inc
      $ 2.095
      (-66.21%)
      		5.69M
      CDTGCDT Environmental Technology Investment Holdings Ltd
      $ 1.87
      (-51.30%)
      		2.28M
      MODVModivCare Inc
      $ 6.51
      (-47.88%)
      		2.73M
      AIFUAIX Inc
      $ 0.420501
      (-47.76%)
      		7.83M
      MRSNMersana Therapeutics Inc
      $ 0.691
      (-46.85%)
      		58.31M
      CDTConduit Pharmaceuticals Inc
      $ 0.1214
      (48.05%)
      		1.17B
      NVDANVIDIA Corporation
      $ 135.91
      (-3.00%)
      		207.53M
      RGTIRigetti Computing Inc
      $ 8.9299
      (-11.06%)
      		178.82M
      VMARVision Marine Technologies Inc
      $ 2.14
      (40.79%)
      		175.57M
      DATSDatChat Inc
      $ 4.8105
      (49.86%)
      		158.65M

      EMBC Discussion

      View Posts
      makinezmoney makinezmoney 3 years ago
      $EMBC: Spun-off from BectonDickenson.... now $30.20


      Could come even lower to sub $15 and then I'll consider a stake in this


      https://finance.yahoo.com/news/bd-announces-completion-embecta-corp-105000224.html


      Here is the most current Investor DECK........


      https://investors.embecta.com/static-files/cbb07e14-b84a-4c10-a6a8-219014e2a5d4


      GO $EMBC
      👍️0

      Your Recent History

      NASDAQ
      EMBC
      Embecta
      TSXV
      JES.P
      Jesmond Capital
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads